Maker Of Antipsychotic Drug Tells Federal Circuit Patent Is Infringed
WASHINGTON, D.C. — In a Jan. 26 cross-appellant brief Forest Laboratories LLC argued that although a Delaware federal judge properly determined that two claims of the patented atypical antipsychotic drug Saphris...To view the full article, register now.
Already a subscriber? Click here to view full article